Daniel R. Chevallard

Companies

• LENZ Therapeutics, Inc.Chief financial officer Mar 25, 2024 to now¹
• Viracta Therapeutics, Inc.Chief financial officer Mar 30, 2021 to Mar 13, 2024²
• Viracta Therapeutics, Inc.Chief operating officer Mar 30, 2021 to Mar 13, 2024²
• Viracta Therapeutics, Inc.Chief executive officer Feb 24, 2021 to Feb 24, 2021³
• Regulus Therapeutics Inc.Chief financial officer May 10, 2017 to Jul 2, 2019⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• LTLENZ Therapeutics, Inc. LENZ12,886 shares⁵$46.0K at $3.57Mar 27, 2026
• VTViracta Therapeutics, Inc.102,306 shares⁶Feb 27, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Mar 27, 2026Bought 7,500 shares at $8.57 of LENZ Therapeutics, Inc.⁵
• Nov 7, 2025Bought 2,178 shares at $22.76 of LENZ Therapeutics, Inc.⁷
• Nov 7, 2025Bought 20 shares at $22.71 of LENZ Therapeutics, Inc.⁷
• May 14, 2024Bought 3,188 shares at $15.68 of LENZ Therapeutics, Inc.⁸
• Feb 27, 2024Sold 3,405 shares at $0.73 of Viracta Therapeutics, Inc.⁶
• Feb 25, 2024Exercised options 6,889 shares of Viracta Therapeutics, Inc.⁶
• Nov 28, 2023Sold 3,720 shares at $0.50 of Viracta Therapeutics, Inc.⁹
• Nov 25, 2023Exercised options 6,889 shares of Viracta Therapeutics, Inc.⁹
• Aug 28, 2023Sold 3,512 shares at $1.45 of Viracta Therapeutics, Inc.¹⁰
• Aug 25, 2023Exercised options 6,888 shares of Viracta Therapeutics, Inc.¹⁰
• May 25, 2023Sold 3,635 shares at $1.42 of Viracta Therapeutics, Inc.¹¹
• May 25, 2023Exercised options 6,889 shares of Viracta Therapeutics, Inc.¹¹
• Feb 27, 2023Sold 3,599 shares at $1.68 of Viracta Therapeutics, Inc.¹²
• Feb 25, 2023Exercised options 6,889 shares of Viracta Therapeutics, Inc.¹²
• Nov 28, 2022Sold 3,532 shares at $2.72 of Viracta Therapeutics, Inc.¹³
• Nov 25, 2022Exercised options 6,889 shares of Viracta Therapeutics, Inc.¹³
• Aug 26, 2022Sold 3,655 shares at $4.02 of Viracta Therapeutics, Inc.¹⁴
• Aug 25, 2022Exercised options 6,889 shares of Viracta Therapeutics, Inc.¹⁴
• May 26, 2022Sold 3,596 shares at $1.90 of Viracta Therapeutics, Inc.¹⁵
• May 25, 2022Exercised options 6,889 shares of Viracta Therapeutics, Inc.¹⁵
• Feb 28, 2022Sold 3,998 shares at $2.78 of Viracta Therapeutics, Inc.¹⁶
• Feb 25, 2022Exercised options 6,889 shares of Viracta Therapeutics, Inc.¹⁶
• Nov 29, 2021Sold 4,325 shares at $4.82 of Viracta Therapeutics, Inc.¹⁷
• Nov 26, 2021Sold 3,254 shares at $4.80 of Viracta Therapeutics, Inc.¹⁷
• Nov 25, 2021Exercised options 13,777 shares of Viracta Therapeutics, Inc.¹⁷